Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;16(12):e74932.
doi: 10.7759/cureus.74932. eCollection 2024 Dec.

Robotic Surgery for Benign Hysterectomy: A Real-World Study From India

Affiliations

Robotic Surgery for Benign Hysterectomy: A Real-World Study From India

Raman Patel et al. Cureus. .

Abstract

Background In gynecology, hysterectomy is a common surgical procedure for benign conditions. This study was conducted to assess the short-term clinical outcomes of robotic-assisted hysterectomy in the Indian population. Methods We performed a retrospective chart review of patients who underwent robotic-assisted benign hysterectomy procedures between December 2021 and July 2024. A single senior surgeon collected clinical data points related to patient demographics, comorbidities, and surgical outcomes. Results A total of 113 patients with a mean age of 45.39 ± 9.04 years and a body mass index of 29.07 ± 4.69 kg/m2 were included in the study. The mean operating room time was 178.41 ± 18.65 minutes, while the estimated blood loss and length of hospital stay were 23.85 ± 5.84 mL and 2.86 ± 0.42 days, respectively. The mean ambulation time was 21.22 ± 3.10 hours. There were only three post-operative complications: urine leakage in two (1.77%) patients and intestinal obstruction due to an ileal adhesion in one (0.88%) patient. Conclusion There are potential advantages to the robotic-assisted hysterectomy in terms of blood loss, length of hospital stay, and intra- and post-operative complications. The study's conclusions support the use of robotic assistance in the surgical management of benign hysterectomy.

Keywords: adnexal masses; endometrioma; hysterectomy; robotic surgery; uterine leiomyoma.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Zydus Hospital Ethics Committee issued approval N/A. This study was performed in line with the principles of the Declaration of Helsinki and the applicable guidelines for good clinical practice (GCP). The ethical approval for the study was obtained from the Zydus Hospital Ethics Committee vide letter dated September 10, 2024. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

References

    1. Multi-institutional trends in gynecological robotic surgery in India: a real-world scenario. Sinha R, Jain V, Somashekhar SP, et al. Cureus. 2023;15:0. - PMC - PubMed
    1. Health economics of hysterectomy. Garry R. Best Pract Res Clin Obstet Gynaecol. 2005;19:451–465. - PubMed
    1. Hysterectomy for benign disease. Falcone T, Walters MD. Obstet Gynecol. 2008;111:753–767. - PubMed
    1. Prevalence, sociodemographic determinants and self-reported reasons for hysterectomy in India. Shekhar C, Paswan B, Singh A. Reprod Health. 2019;16:118. - PMC - PubMed
    1. Surgical approach to hysterectomy for benign gynaecological disease. Pickett CM, Seeratan DD, Mol BW, Nieboer TE, Johnson N, Bonestroo T, Aarts JW. Cochrane Database Syst Rev. 2023;8:0. - PMC - PubMed

LinkOut - more resources